Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-03-28
2010-10-12
Strzelecka, Teresa E (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07811762
ABSTRACT:
Methods of identifying polymorphisms associated with hereditary spastic paraplegia (SPG), are described. The polymorphisms associated with SPG include specific mutations in the receptor expression enhancing protein 1 (REEP1) gene. Also described are methods of diagnosis of SPG.
REFERENCES:
patent: 6924126 (2005-08-01), Weissenbach et al.
patent: 7108925 (2006-09-01), Campbell
patent: 2003/0224968 (2003-12-01), Fink et al.
patent: 2005/0266479 (2005-12-01), Weissenbach et al.
patent: 2006/0057640 (2006-03-01), Matsunami et al.
patent: 2006/0073478 (2006-04-01), Fink et al.
patent: 2007/0015202 (2007-01-01), Fink et al.
Ashley-Koch, A., et al., “Fine Mapping and Genetic Heterogeneity in the Pure Form of Autosomal Dominant Familial Spastic Paraplegia,”Neurogenetics, 3:91-97 (2001).
Evans, K., et al., “Interaction of Two Hereditary Spastic Paraplegia Gene Products, Spastin and Atlastin, Suggests a Common Pathway for Axonal Maintenance,”PNAS, 103:10666-10671 (2006).
Fink, J.K., et al., “Hereditary Spastic Paragplegia: Genetic Heterogeneity and Genotype-Phenotype Correlation,”Seminars in Neurology, 19:301-309 (1999).
Fortini, D., et al., “Current Insights Into Familial Spastic Paraparesis: New Advances in an Old Disease,”Functional Neurology, 18:43-49 (2003).
Hansen, J.J., et al., “Hereditary Spastic Paraplegia SPG13 is Associated with a Mutation in the Gene Encoding the Mitochondrial Chaperonin Hsp60,”Am. J. Hum. Genet., 70:1328-1332 (2002).
Hazan, J. et al., “Spastin, a New AAA Protein, is Altered in the Most Frequent Form of Autosomal Dominant Spastic Paraplegia,”Nat. Genet. 23:296-303 (1999).
Hentati, A., et al. “Linkage of a Locus for Autosomal Dominant Familial Spastic Paraplegia to Chromosome 2p Markers,”Human Molecular Genetics, 3:1867-1871 (1994).
Hiltunen, M., et al., “Butyrylcholinesterase K. Variant and Apolipoprotein E4 Genes to Not Act in Synergy in Finnish Late-Onset Alzheimer's Disease Patients,”Neuroscience Letters, 250:69-71 (1998).
Ishikawa, K. et al., “An Autosomal Dominant Cerebellar Ataxia Linked to Chromosome 16q22.1 Is Associated with A Single-Nucleotide Substitution in the 5′ Untranslated Region of the Gene Encoding a Protein Spectrin Repeat and Rho Guanine-Nucleotide Exchange-Factor Domains,”Am. J. Hum. Genet. 77:280-296 (2005).
Orlacchio, A., “New Locus for Hereditary Spastic Paraplegia Maps to Chromosome 1p31.1-1p21.1,”Ann. Neurol. 58:423-429 (2005).
Raskind, W.H., et al., “Familial Spastic Paraparesis: Evaluation of Locus Heterogeneity, Anticipation, and Haplotype Mapping of the SPG4 Locus on the Short Arm of Chromosome 2,”Am. J. Med. Genet., 74:26-36 (1997).
Reid, E., et al., A Kinesin Heavy Chain (KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10),Am. J. Hum. Genet. 71:1189-1194 (2002).
Reid, E., et al., “A New locus for Autosomal Dominant “Pure” Hereditary Spastic Paraplegia Mapping to Chromosome 12q13, and Evidence for Further Genetic Heterogeneity,”Am. J. Hum. Genet. 65:757-763 (1999).
Reid, E., “Science in Motion: Common Molecular Pathological Themes Emerge in the Hereditary Spastic Paraplegias,”J. Med. Genet.40: 81-86 (2003).
Scott, W.K. et al., “Locus Heterogeneity, Anticipation and Reduction of the Chromosome 2p Minimal Candidate Region in Autosomal Dominant Familial Spastic Paraplegia,”Neurogenetics, 1:95-102 (1997).
Svenson, I.K., et al., “Identification and Expression Analysis of Spastin Gene Mutations in Hereditary Spastic Paraplegia,”Am. J. Hum. Genet. 68:1077-1085 (2001).
Svenson, I.K., et al., Intragenic Modifiers of Hereditary Spastic Paraplegia Due to Spastin Gene Mutations,Neurogenetics5:157-164 (2004).
Tallaksen, C.M.E., et al., “Recent Advances in Hereditary Spastic Paraplegia,”Curr. Opinion in Neurology, 14:457-463 (2001).
Züchner, S., et al. “A New Locus for Dominant Hereditary Spastic Paraplegia Maps to Chromosome 2p12,”Neurogenetics, 7:127-129 (2006).
Züchner, S., et al. “Mutations in the Novel Mitochondrial Protein REEP1 Cause Hereditary Spastic Paraplegia Type 31”Am. J. Hum. Genet. 79:365-369 (2006).
Zhao, X., et al. “Mutations in a Newly Identified GTPase Gene Cause Autosomal Dominant Hereditary Spastic Paraplegia,”Nature Genetics, 29: 326-331 (2001).
Finsterer, J., “Hereditäre Spastische Paraplegien,”Nervenarzt, 74:497-504 (2003).
Saito, H., et al., “RTP Family Members Induce Functional Expression of Mammalian Odorant Receptors,”Cell, 119:679-691 (2004).
Database SNPDB, NCBI: “Single Nucleotide Polymorphism,” Accession No. rs3087642 (2002).
Ashley-Koch Allison
Braastad Corey
Jones Jeffrey G.
Nagan Narasimhan
Pericak-Vance Margaret
Duke University
Hamilton Brook Smith & Reynolds P.C.
Strzelecka Teresa E
LandOfFree
Identification of a novel gene underlying familial spastic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification of a novel gene underlying familial spastic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of a novel gene underlying familial spastic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4161759